Allon Therapeutics, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2012
Allon Therapeutics, Inc. reported unaudited earnings results for the first quarter ended March 31, 2012. For the quarter, the company reported net loss of $2,778,704 or $0.03 per share compared to a net loss of $2,974,076 or $0.04 per share for the three months ended March 31, 2011, representing a decrease in net loss of $195,372. The company earned interest revenue of $43 during the three months ended March 31, 2012 compared to $4,900 for the same period in 2011.